Temat: "Influenza, Human" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Prevalence of chronic conditions and influenza vaccination coverage rates in Germany: Results of a health insurance claims data analysis.
Autorzy:: Damm O; Sanofi-Aventis Deutschland GmbH, Berlin, Germany.
Krefft A; Sanofi-Aventis Deutschland GmbH, Berlin, Germany.
Ahlers J; Sanofi-Aventis Deutschland GmbH, Berlin, Germany.
Kramer R; Sanofi-Aventis Deutschland GmbH, Berlin, Germany.
Witte J; School of Public Health, Bielefeld University, Bielefeld, Germany.; Vandage GmbH, Bielefeld, Germany.
Batram M; Vandage GmbH, Bielefeld, Germany.
Schelling J; Medical Faculty, Ludwig-Maximilians-University, Munich, Germany.
Greiner W; School of Public Health, Bielefeld University, Bielefeld, Germany.; Pokaż więcej
Źródło:: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2023 Jan; Vol. 17 (1), pp. e13054. Date of Electronic Publication: 2022 Oct 01.
Typ publikacji:: Journal Article
MeSH Terms:: Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza Vaccines*
Humans ; Vaccination Coverage ; Prevalence ; Vaccination ; Germany/epidemiology ; Chronic Disease ; Seasons ; Insurance, Health ; Data Analysis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Influenza vaccination and stroke risk: additional factors should be considered.
Autorzy:: Chu WM; Department of Family Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Chen CW; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Wei JC; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Department of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan; Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan. Electronic address: .; Pokaż więcej
Źródło:: The Lancet. Public health [Lancet Public Health] 2023 Feb; Vol. 8 (2), pp. e96.
Typ publikacji:: Letter
MeSH Terms:: Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Stroke*/epidemiology
Stroke*/prevention & control
Humans ; Risk Factors ; Vaccination

Opinia redakcyjna

na półce

Szczegóły

Skocz do pozycji: 3.

Tytuł:: Influenza vaccination and stroke risk: additional factors should be considered - Author's Reply.
Autorzy:: Holodinsky JK; Department of Clinical Neurosciences, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada. Electronic address: .
Hill MD; Department of Clinical Neurosciences, Department of Community Health Sciences, Department of Medicine, Department of Radiology, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.; Pokaż więcej
Źródło:: The Lancet. Public health [Lancet Public Health] 2023 Feb; Vol. 8 (2), pp. e97.
Typ publikacji:: Letter
MeSH Terms:: Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Stroke*/epidemiology
Stroke*/prevention & control
Humans ; Vaccination

Opinia redakcyjna

na półce

Szczegóły

Skocz do pozycji: 4.

Tytuł:: Severity of influenza illness by seasonal influenza vaccination status among hospitalised patients in four South American countries, 2013-19: a surveillance-based cohort study.
Autorzy:: Regan AK; School of Nursing and Health Professions, University of San Francisco, Orange, CA, USA; Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, USA. Electronic address: .
Arriola CS; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Couto P; Health Emergencies Program, Pan American Health Organization, Washington, DC, USA.
Duca L; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Loayza S; Department of Family, Health Promotion, and Life Course, Pan American Health Organization, Washington, DC, USA.
Nogareda F; Department of Family, Health Promotion, and Life Course, Pan American Health Organization, Washington, DC, USA.
de Almeida WAF; Ministry of Health Brazil, Brasília, Federal District, Brazil.
Antman J; Surveillance Area, Directorate of Epidemiology, Ministry of Health, Buenos Aires, Argentina; Consultant to The Task Force for Global Health, Decatur, GA, USA.
Araya S; Expanded Program on Immunizations, Ministry of Public Health and Social Welfare, Asunción, Paraguay.
Avendaño Vigueras MA; Department of Immunizations, Ministry of Health, Santiago, Chile.
Battaglia Paredes SC; General Directorate of Health Surveillance, Ministry of Public Health and Social Welfare, Asunción, Paraguay.
Brstilo IF; Department of Immunizations, Ministry of Health, Santiago, Chile.
Bustos P; Public Health Institute, Ministry of Health, Santiago, Chile.
Fandiño ME; Surveillance Area, Directorate of Epidemiology, Ministry of Health, Buenos Aires, Argentina.
Fasce R; Public Health Institute, Ministry of Health, Santiago, Chile.
Giovacchini CM; Surveillance Area, Directorate of Epidemiology, Ministry of Health, Buenos Aires, Argentina.
González Caro CI; Department of Immunizations, Ministry of Health, Santiago, Chile.
von Horoch M; General Directorate of Health Surveillance, Ministry of Public Health and Social Welfare, Asunción, Paraguay.
Del Valle Juarez M; Directorate for the Control of Immunopreventable Diseases, Ministry of Health, Buenos Aires, Argentina.
Katz N; Directorate for the Control of Immunopreventable Diseases, Ministry of Health, Buenos Aires, Argentina.
Olivares MF; Department of Epidemiology, Ministry of Health, Santiago, Chile.
da Silva DA; Ministry of Health Brazil, Brasília, Federal District, Brazil.
da Silva ET; Fiocruz Brasília, Rio de Janeiro, Brazil.
Sotomayor V; Department of Epidemiology, Ministry of Health, Santiago, Chile.
Vergara N; Department of Epidemiology, Ministry of Health, Santiago, Chile.
Azziz-Baumgartner E; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: .
Ropero AM; Department of Family, Health Promotion, and Life Course, Pan American Health Organization, Washington, DC, USA.; Pokaż więcej
Źródło:: The Lancet. Infectious diseases [Lancet Infect Dis] 2023 Feb; Vol. 23 (2), pp. 222-232. Date of Electronic Publication: 2022 Oct 04.
Typ publikacji:: Journal Article
MeSH Terms:: Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza Vaccines*
Child ; Humans ; Child, Preschool ; Aged ; Seasons ; Cohort Studies ; Hospital Mortality ; Hospitalization ; Vaccination ; Brazil/epidemiology

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 5.

Tytuł:: Practice patterns and perceptions of influenza testing amongst pediatric urgent care providers.
Autorzy:: Shaukat H; Division of Emergency Medicine, Children's National Health System, Wshington, DC, USA; George Washington University School of Medicine and Health Sciences, Washington, DC, USA. Electronic address: .
Wang S; Division of Emergency Medicine, Children's National Health System, Wshington, DC, USA.
Kim D; Division of Emergency Medicine, Children's National Health System, Wshington, DC, USA.
Koutroulis I; Division of Emergency Medicine, Children's National Health System, Wshington, DC, USA; George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
Berkowitz D; Division of Emergency Medicine, Children's National Health System, Wshington, DC, USA; George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
Breslin K; Division of Emergency Medicine, Children's National Health System, Wshington, DC, USA; George Washington University School of Medicine and Health Sciences, Washington, DC, USA.; Pokaż więcej
Źródło:: Diagnostic microbiology and infectious disease [Diagn Microbiol Infect Dis] 2023 Feb; Vol. 105 (2), pp. 115818. Date of Electronic Publication: 2022 Sep 18.
Typ publikacji:: Journal Article
MeSH Terms:: Influenza, Human*/diagnosis
Influenza, Human*/drug therapy
Child ; Humans ; Ambulatory Care ; Outpatients ; Diagnostic Tests, Routine ; Surveys and Questionnaires ; Antiviral Agents/therapeutic use ; Sensitivity and Specificity

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 6.

Tytuł:: A Multicenter, Prospective, Randomized, Parallel-Group Trial on the Effects of Temporary Methotrexate Discontinuation for One Week Versus Two Weeks on Seasonal Influenza Vaccination in Patients With Rheumatoid Arthritis.
Autorzy:: Park JK; Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, and Seoul National University Hospital, Seoul, Republic of Korea.
Lee YJ; Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea, and Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Gyeonggi-do, Republic of Korea.
Shin K; Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Kang EH; Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Gyeonggi-do, Republic of Korea.
Ha YJ; Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Gyeonggi-do, Republic of Korea.
Park JW; Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Kim MJ; Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Kim MH; Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Choi SR; Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Jung Y; Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Lee JH; Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Gyeonggi-do, Republic of Korea.
In Jung J; Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Kim JY; Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Winthrop KL; Division of Infectious Diseases, Oregon Health and Science University, Portland.
Lee EB; Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea, and Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Republic of Korea.; Pokaż więcej
Źródło:: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2023 Feb; Vol. 75 (2), pp. 171-177. Date of Electronic Publication: 2022 Dec 07.
Typ publikacji:: Randomized Controlled Trial; Multicenter Study; Journal Article
MeSH Terms:: Antirheumatic Agents*/therapeutic use
Arthritis, Rheumatoid*
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*/administration & dosage
Influenza, Human*/prevention & control
Influenza, Human*/chemically induced
Influenza, Human*/drug therapy
Humans ; Influenza A Virus, H3N2 Subtype ; Methotrexate/therapeutic use ; Prospective Studies ; Seasons ; Vaccination

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 7.

Tytuł:: Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar.
Autorzy:: Tayar E; Community Medicine Department, Hamad Medical Corporation, Doha, Qatar. Electronic address: .
Abdeen S; Community Medicine Department, Hamad Medical Corporation, Doha, Qatar. Electronic address: .
Abed Alah M; Community Medicine Department, Hamad Medical Corporation, Doha, Qatar. Electronic address: .
Chemaitelly H; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA. Electronic address: .
Bougmiza I; Community Medicine Department, Primary Health Care Corporation, Doha, Qatar; Community Medicine Department, College of Medicine, Sousse University, Tunisia. Electronic address: .
Ayoub HH; Mathematics Program, Department of Mathematics, Statistics, and Physics, College of Arts and Sciences, Qatar University, Doha, Qatar. Electronic address: .
Kaleeckal AH; Business Intelligence and Operational Performance Unit, Hamad Medical Corporation, Doha, Qatar. Electronic address: .
Latif AN; Business Intelligence and Operational Performance Unit, Hamad Medical Corporation, Doha, Qatar. Electronic address: .
Shaik RM; Business Intelligence and Operational Performance Unit, Hamad Medical Corporation, Doha, Qatar. Electronic address: .
Al-Romaihi HE; Ministry of Public Health, Doha, Qatar. Electronic address: .
Al-Thani MH; Ministry of Public Health, Doha, Qatar. Electronic address: .
Bertollini R; Ministry of Public Health, Doha, Qatar. Electronic address: .
Abu-Raddad LJ; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA; Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar. Electronic address: .
Al-Khal A; Medical Education Department, Hamad Medical Corporation, Doha, Qatar. Electronic address: .; Pokaż więcej
Źródło:: Journal of infection and public health [J Infect Public Health] 2023 Feb; Vol. 16 (2), pp. 250-256. Date of Electronic Publication: 2022 Dec 26.
Typ publikacji:: Journal Article
MeSH Terms:: COVID-19*/epidemiology
COVID-19*/prevention & control
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Humans ; SARS-CoV-2 ; Qatar/epidemiology ; COVID-19 Vaccines ; Case-Control Studies ; Vaccination ; Health Personnel

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 8.

Tytuł:: Unintended health benefits of adopting preventive behaviors during a virus outbreak.
Autorzy:: Hong SC; Department of Economics, Seoul National University, Seoul, Korea.
Lee E; Department of Economics, University of California-Davis, Davis, California, USA.
Oh S; Department of Economics, University of California-Davis, Davis, California, USA.; Pokaż więcej
Źródło:: Health economics [Health Econ] 2023 Feb; Vol. 32 (2), pp. 324-342. Date of Electronic Publication: 2022 Nov 21.
Typ publikacji:: Journal Article
MeSH Terms:: Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza A Virus, H1N1 Subtype*
Humans ; Disease Outbreaks/prevention & control

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 9.

Tytuł:: Mortality in cancer patients with SARS-CoV-2 or seasonal influenza: an observational cohort study from a German-wide hospital network.
Autorzy:: Kodde C; Department of Respiratory Diseases 'Heckeshorn', Helios Clinic Emil-Von-Behring, Berlin, Germany. .
Bonsignore M; Division of Infectious Diseases and Prevention, Helios Hospitals Duisburg, Duisburg, Germany.
Schöndube D; Department of Oncology and Hematology, Helios Klinikum Bad Saarow, Bad Saarow, Germany.
Bauer T; Department of Respiratory Diseases 'Heckeshorn', Helios Clinic Emil-Von-Behring, Berlin, Germany.
Hohenstein S; Heart Center Leipzig at University of Leipzig and Leipzig Heart Institute, Leipzig, Germany.
Bollmann A; Heart Center Leipzig at University of Leipzig and Leipzig Heart Institute, Leipzig, Germany.
Meier-Hellmann A; Helios Kliniken, Berlin, Germany.
Kuhlen R; Helios Health, Berlin, Germany.
Nachtigall I; Division of Infectious Diseases and Infection Prevention, Helios Hospital Emil-Von-Behring, Berlin, Germany.; Institute of Hygiene and Environmental Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Pokaż więcej
Źródło:: Infection [Infection] 2023 Feb; Vol. 51 (1), pp. 119-127. Date of Electronic Publication: 2022 Jun 03.
Typ publikacji:: Observational Study; Journal Article
MeSH Terms:: COVID-19*/epidemiology
Influenza, Human*/complications
Influenza, Human*/epidemiology
Neoplasms*/complications
Neoplasms*/epidemiology
Humans ; Male ; SARS-CoV-2 ; Pandemics ; Seasons ; Hospitals ; Cohort Studies ; Hospital Mortality ; Retrospective Studies

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 10.

Tytuł:: Influenza antivirals and their role in pandemic preparedness.
Autorzy:: Jones JC; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, USA.
Yen HL; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region of China.
Adams P; Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC, USA.
Armstrong K; Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC, USA.
Govorkova EA; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, USA. Electronic address: .; Pokaż więcej
Źródło:: Antiviral research [Antiviral Res] 2023 Feb; Vol. 210, pp. 105499. Date of Electronic Publication: 2022 Dec 23.
Typ publikacji:: Review; Journal Article
MeSH Terms:: Antiviral Agents*/pharmacology
Antiviral Agents*/therapeutic use
Influenza, Human*/drug therapy
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Humans ; Drug Resistance, Viral ; Enzyme Inhibitors/pharmacology ; Enzyme Inhibitors/therapeutic use ; Neuraminidase/antagonists & inhibitors ; Oseltamivir/pharmacology ; Pandemics/prevention & control

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 11.

Tytuł:: Designing multi-epitope mRNA construct as a universal influenza vaccine candidate for future epidemic/pandemic preparedness.
Autorzy:: Rcheulishvili N; Department of Pharmacology, School of Medicine, Southern University of Science and Technology, Shenzhen 518000, China.
Mao J; Department of Pharmacology, School of Medicine, Southern University of Science and Technology, Shenzhen 518000, China.
Papukashvili D; Department of Pharmacology, School of Medicine, Southern University of Science and Technology, Shenzhen 518000, China.
Liu C; Department of Pharmacology, School of Medicine, Southern University of Science and Technology, Shenzhen 518000, China.
Wang Z; Department of Pharmacology, School of Medicine, Southern University of Science and Technology, Shenzhen 518000, China.
Zhao J; Department of Pharmacology, School of Medicine, Southern University of Science and Technology, Shenzhen 518000, China.
Xie F; Department of Pharmacology, School of Medicine, Southern University of Science and Technology, Shenzhen 518000, China.
Pan X; Department of Pharmacology, School of Medicine, Southern University of Science and Technology, Shenzhen 518000, China.
Ji Y; Department of Pharmacology, School of Medicine, Southern University of Science and Technology, Shenzhen 518000, China.
He Y; Department of Pharmacology, School of Medicine, Southern University of Science and Technology, Shenzhen 518000, China. Electronic address: .
Wang PG; Department of Pharmacology, School of Medicine, Southern University of Science and Technology, Shenzhen 518000, China. Electronic address: .; Pokaż więcej
Źródło:: International journal of biological macromolecules [Int J Biol Macromol] 2023 Jan 31; Vol. 226, pp. 885-899. Date of Electronic Publication: 2022 Dec 12.
Typ publikacji:: Journal Article
MeSH Terms:: Influenza Vaccines*
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Orthomyxoviridae*
Humans ; Epitopes/genetics ; Pandemics/prevention & control ; Molecular Docking Simulation ; Antibodies, Viral

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 12.

Tytuł:: Mild and asymptomatic influenza B virus infection among unvaccinated pregnant persons: Implication for effectiveness of non-pharmaceutical intervention and vaccination to prevent influenza.
Autorzy:: Chen L; Suzhou Center for Disease Control and Prevention, Suzhou, Jiangsu Province, PR China.
Levine MZ; U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
Zhou S; U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
Bai T; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, PR China.
Pang Y; Suzhou Center for Disease Control and Prevention, Suzhou, Jiangsu Province, PR China.
Bao L; Suzhou Center for Disease Control and Prevention, Suzhou, Jiangsu Province, PR China.
Tan Y; Suzhou Center for Disease Control and Prevention, Suzhou, Jiangsu Province, PR China.
Cui P; Suzhou Center for Disease Control and Prevention, Suzhou, Jiangsu Province, PR China.
Zhang R; U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
Millman AJ; U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
Greene CM; U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
Zhang Z; Suzhou Municipal Hospital, Suzhou, Jiangsu Province, PR China.
Wang Y; Wuzhong Maternal and Child Health Care Institute, Suzhou, Jiangsu Province, PR China.
Zhang J; Suzhou Center for Disease Control and Prevention, Suzhou, Jiangsu Province, PR China. Electronic address: sz_.; Pokaż więcej
Źródło:: Vaccine [Vaccine] 2023 Jan 16; Vol. 41 (3), pp. 694-701. Date of Electronic Publication: 2022 Dec 14.
Typ publikacji:: Journal Article
MeSH Terms:: Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Herpesviridae Infections*
Influenza Vaccines*
Humans ; Female ; Pregnancy ; Influenza A Virus, H3N2 Subtype ; Influenza B virus ; Vaccination

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 13.

Tytuł:: Vaccination against influenza, measles, pertussis and varicella in workers in healthcare facilities in France: A national cross-sectional study in 2019.
Autorzy:: Vaux S; Santé publique France (French Institute for Public Health Surveillance), Saint-Maurice, France. Electronic address: .
Fonteneau L; Santé publique France (French Institute for Public Health Surveillance), Saint-Maurice, France.
Péfau M; Nouvelle Aquitaine Healthcare-Associated Infection Control Centre, Bordeaux University Hospital, Bordeaux, France.
Venier AG; Nouvelle Aquitaine Healthcare-Associated Infection Control Centre, Bordeaux University Hospital, Bordeaux, France.
Gautier A; Santé publique France (French Institute for Public Health Surveillance), Saint-Maurice, France.
Altrach SS; Santé publique France (French Institute for Public Health Surveillance), Saint-Maurice, France.
Parneix P; Nouvelle Aquitaine Healthcare-Associated Infection Control Centre, Bordeaux University Hospital, Bordeaux, France.
Levy-Bruhl D; Santé publique France (French Institute for Public Health Surveillance), Saint-Maurice, France.; Pokaż więcej
Źródło:: Vaccine [Vaccine] 2023 Jan 16; Vol. 41 (3), pp. 812-820. Date of Electronic Publication: 2022 Dec 15.
Typ publikacji:: Journal Article
MeSH Terms:: Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza Vaccines*
Whooping Cough*/epidemiology
Whooping Cough*/prevention & control
Measles*/prevention & control
Chickenpox*
Humans ; Adult ; Cross-Sectional Studies ; Vaccination ; Health Personnel ; Delivery of Health Care ; France/epidemiology

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 14.

Tytuł:: The impact of seasonal influenza vaccination uptake on COVID-19 vaccination attitudes in a rural area in Greece.
Autorzy:: Papazachariou A; Department of Internal Medicine, University Hospital of Heraklion, Heraklion, Greece; Department of Internal Medicine, General Hospital of Sitia, Sitia, Greece.
Tsioutis C; School of Medicine, European University Cyprus, Nicosia, Cyprus.
Lytras T; School of Medicine, European University Cyprus, Nicosia, Cyprus.
Malikides O; Department of Internal Medicine, University Hospital of Heraklion, Heraklion, Greece.
Stamatelatou M; Department of Internal Medicine, General Hospital of Sitia, Sitia, Greece.
Vasilaki N; Department of Internal Medicine, General Hospital of Sitia, Sitia, Greece.
Milioni A; Department of Otorhinolaryngology, 'Elpis' General Hospital, Athens, Greece.
Dasenaki M; Department of Internal Medicine, General Hospital of Sitia, Sitia, Greece.
Spernovasilis N; School of Medicine, University of Crete, Heraklion, Greece; Department of Infectious Diseases, German Oncology Center, Limassol, Cyprus. Electronic address: .; Pokaż więcej
Źródło:: Vaccine [Vaccine] 2023 Jan 16; Vol. 41 (3), pp. 821-825. Date of Electronic Publication: 2022 Dec 15.
Typ publikacji:: Journal Article
MeSH Terms:: COVID-19*/epidemiology
COVID-19*/prevention & control
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza Vaccines*
Female ; Humans ; Aged ; Aged, 80 and over ; Greece/epidemiology ; COVID-19 Vaccines ; Cross-Sectional Studies ; Seasons ; Retrospective Studies ; Vaccination ; Attitude

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 15.

Tytuł:: Disappearance and Re-Emergence of Influenza during the COVID-19 Pandemic: Association with Infection Control Measures.
Autorzy:: Takeuchi H; Division of Developmental Cognitive Neuroscience, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan.
Kawashima R; Division of Developmental Cognitive Neuroscience, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan.; Smart Aging Research Center, Tohoku University, Sendai 980-8575, Japan.; Department of Advanced Brain Science, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan.; Pokaż więcej
Źródło:: Viruses [Viruses] 2023 Jan 13; Vol. 15 (1). Date of Electronic Publication: 2023 Jan 13.
Typ publikacji:: Journal Article
MeSH Terms:: COVID-19*/epidemiology
COVID-19*/prevention & control
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Humans ; Pandemics/prevention & control ; Infection Control ; Disease Outbreaks/prevention & control ; Seasons

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Enhanced passive safety surveillance of Influvac® and Influvac® Tetra: Results from seven consecutive seasons.
Autorzy:: Moeller-Arendt M; Product Safety and Risk Management, Viatris, Hannover, Germany. Electronic address: .
van de Witte S; Abbott Healthcare Products B.V, Weesp, the Netherlands.
Nauta J; Abbott Healthcare Products B.V, Weesp, the Netherlands.
de Voogd H; Global Clinical Development, Viatris, the Netherlands.
Rogoll J; Global Pharmacovigilance, Abbott Laboratories, Hannover, Germany.
Nisslein T; Global Pharmacovigilance, Abbott Laboratories, Hannover, Germany.; Pokaż więcej
Źródło:: Vaccine [Vaccine] 2023 Jan 09; Vol. 41 (2), pp. 606-613. Date of Electronic Publication: 2022 Dec 12.
Typ publikacji:: Journal Article
MeSH Terms:: Influenza Vaccines*/adverse effects
Influenza, Human*/prevention & control
Influenza, Human*/etiology
Adult ; Child ; Humans ; Aged ; Seasons ; Vaccination/adverse effects

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 17.

Tytuł:: Novel modelling approaches to predict the role of antivirals in reducing influenza transmission.
Autorzy:: Asher J; Leidos, Reston, Virginia, United States of America.
Lemenuel-Diot A; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Clay M; Leidos, Reston, Virginia, United States of America.
Durham DP; Leidos, Reston, Virginia, United States of America.
Mier-Y-Teran-Romero L; Leidos, Reston, Virginia, United States of America.
Arguello CJ; Leidos, Reston, Virginia, United States of America.
Jolivet S; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Wong DY; Office of the Assistant Secretary for Preparedness and Response, U.S Department of Health and Human Services, Washington, District of Columbia, United States of America.
Kuhlbusch K; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Clinch B; Roche Products Ltd., Welwyn Garden City, United Kingdom.
Charoin JE; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Pokaż więcej
Źródło:: PLoS computational biology [PLoS Comput Biol] 2023 Jan 06; Vol. 19 (1), pp. e1010797. Date of Electronic Publication: 2023 Jan 06 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: Influenza, Human*/drug therapy
Influenza, Human*/prevention & control
Thiepins*/pharmacology
Thiepins*/therapeutic use
Humans ; Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; Oseltamivir/pharmacology ; Oseltamivir/therapeutic use ; Oxazines/pharmacology ; Oxazines/therapeutic use ; Pyridines/pharmacology ; Triazines/pharmacology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: IFI27 transcription is an early predictor for COVID-19 outcomes, a multi-cohort observational study.
Autorzy:: Shojaei M; Department of Intensive Care Medicine, Nepean Hospital, Penrith, NSW, Australia.; Centre for Immunology and Allergy Research, the Westmead Institute for Medical Research, Westmead, NSW, Australia.; Department of Medicine, Sydney Medical School Nepean, Nepean Hospital, University of Sydney, Penrith, NSW, Australia.
Shamshirian A; Gastrointestinal Cancer Research Centre, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Monkman J; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
Grice L; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.; School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, Australia.
Tran M; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.
Tan CW; The Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, VIC, Australia.; Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.
Teo SM; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.
Rodrigues Rossi G; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
McCulloch TR; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
Nalos M; Department of Intensive Care Medicine, Nepean Hospital, Penrith, NSW, Australia.
Raei M; Gastrointestinal Cancer Research Centre, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Razavi A; Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Ghasemian R; Antimicrobial Resistance Research Centre, Department of Infectious Diseases, Mazandaran University of Medical Sciences, Sari, Iran.
Gheibi M; Student Research Committee, School of Allied Medical Sciences, Mazandaran University of Medical Science, Sari, Iran.
Roozbeh F; Mazandaran University of Medical Sciences, Sari, Iran.
Sly PD; Child Health Research Centre, The University of Queensland, South Brisbane, QLD, Australia.
Spann KM; Centre for Immunology and Infection Control, Faculty of Health, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.
Chew KY; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia.
Zhu Y; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia.
Xia Y; School of Science, Edith Cowan University; School of Biomedical Science, University of Western Australia, Perth, WA, Australia.
Wells TJ; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
Senegaglia AC; Complexo Hospital de Clinicas, Universidade Federal do Paraná, Curitiba, Brazil.; Core for Cell Technology, School of Medicine, PontifìciaUniversidade Católica do Paraná, Curitiba, Brazil.
Kuniyoshi CL; Complexo Hospital de Clinicas, Universidade Federal do Paraná, Curitiba, Brazil.; Core for Cell Technology, School of Medicine, PontifìciaUniversidade Católica do Paraná, Curitiba, Brazil.
Franck CL; Complexo Hospital de Clinicas, Universidade Federal do Paraná, Curitiba, Brazil.
Dos Santos AFR; Pontifical Catholic University of Parana, Curitiba, Brazil.
de Noronha L; Pontifical Catholic University of Parana, Curitiba, Brazil.
Motamen S; Department of Medical Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Valadan R; Molecular and Cell Biology Research Centre, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.; Department of Immunology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Amjadi O; Gastrointestinal Cancer Research Centre, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Gogna R; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.; Novo Nordisk Foundation centre for Stem Cell Biology, DanStem, Faculty of Health and Medical Sciences, Champalimaud Centre for the Unknown, Lisbon, Portugal.
Madan E; Campania Centre for the Unknown, Lisbon, Portugal.
Alizadeh-Navaei R; Gastrointestinal Cancer Research Centre, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Lamperti L; Department of Clinical Biochemistry and Immunology, Faculty of Pharmacy, University of Concepcion, Concepcion, Chile.
Zuñiga F; Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Faculty of Pharmacy, Universidad de Concepcion, Concepcion, Chile.
Nova-Lamperti E; Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Faculty of Pharmacy, Universidad de Concepcion, Concepcion, Chile.
Labarca G; Department of Clinical Biochemistry and Immunology, Faculty of Pharmacy, University of Concepcion, Concepcion, Chile.; Faculty of Medicine, Universidad de Concepcion, Concepcion, Chile.
Knippenberg B; Infectious Diseases Department, Royal Darwin Hospital, Darwin, NT, Australia.
Herwanto V; Faculty of Medicine, Universitas Tarumanagara, Jakarta, Indonesia.
Wang Y; Department of Intensive Care Medicine, Nepean Hospital, Penrith, NSW, Australia.; Centre for Immunology and Allergy Research, the Westmead Institute for Medical Research, Westmead, NSW, Australia.; Department of Medicine, Sydney Medical School Nepean, Nepean Hospital, University of Sydney, Penrith, NSW, Australia.
Phu A; Department of Intensive Care Medicine, Nepean Hospital, Penrith, NSW, Australia.; Westmead Clinical School, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
Chew T; Sydney Informatics Hub, Core Research Facilities, University of Sydney, Sydney, NSW, Australia.
Kwan T; Department of Intensive Care Medicine, Nepean Hospital, Penrith, NSW, Australia.
Kim K; Centre for Immunology and Allergy Research, the Westmead Institute for Medical Research, Westmead, NSW, Australia.
Teoh S; Department of Intensive Care Medicine, Nepean Hospital, Penrith, NSW, Australia.
Pelaia TM; Department of Intensive Care Medicine, Nepean Hospital, Penrith, NSW, Australia.
Kuan WS; Emergency Medicine Department, National University Hospital, National University Health System, Singapore, Singapore.; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Jee Y; Emergency Medicine Department, National University Hospital, National University Health System, Singapore, Singapore.
Iredell J; Faculty of Medicine and Health, School of Medical Sciences, University of Sydney, Sydney, NSW, Australia.; Centre for Infectious Diseases and Microbiology, Westmead Institute for Medical Research, Sydney, NSW, Australia.; Westmead Hospital, Western Sydney Local Health District, Sydney, NSW, Australia.
O'Byrne K; Queensland University of Technology, Centre for Genomics and PersonalisedHealth, School of Biomedical Sciences, Brisbane, QLD, Australia.
Fraser JF; Critical Care Research Group, The University of Queensland, Brisbane, QLD, Australia.
Davis MJ; The Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, VIC, Australia.; Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.; Department of Clinical Pathology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.
Belz GT; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
Warkiani ME; Australia Centre for Health Technologies (CHT) & Institute for Biomedical Materials & Devices (IBMD), School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW, Australia.
Gallo CS; Department of Clinical Biochemistry and Immunology, Faculty of Pharmacy, University of Concepcion, Concepcion, Chile.; Exosome Biology Laboratory, Centre for Clinical Diagnostics, University of Queensland Centre for Clinical Research, Royal Brisbane and Women's Hospital, The University of Queensland, Brisbane, QLD, Australia.
Souza-Fonseca-Guimaraes F; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
Nguyen Q; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.
Mclean A; Department of Intensive Care Medicine, Nepean Hospital, Penrith, NSW, Australia.
Kulasinghe A; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
Short KR; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia.
Tang B; Department of Intensive Care Medicine, Nepean Hospital, Penrith, NSW, Australia.; Centre for Immunology and Allergy Research, the Westmead Institute for Medical Research, Westmead, NSW, Australia.; Pokaż więcej
Źródło:: Frontiers in immunology [Front Immunol] 2023 Jan 05; Vol. 13, pp. 1060438. Date of Electronic Publication: 2023 Jan 05 (Print Publication: 2022).
Typ publikacji:: Observational Study; Journal Article
MeSH Terms:: COVID-19*/diagnosis
COVID-19*/genetics
Influenza A Virus, H1N1 Subtype*
Influenza, Human*/diagnosis
Influenza, Human*/epidemiology
Influenza, Human*/genetics
Humans ; SARS-CoV-2/genetics ; Biomarkers ; Membrane Proteins/genetics

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 19.

Tytuł:: Mitigating co-circulation of seasonal influenza and COVID-19 pandemic in the presence of vaccination: A mathematical modeling approach.
Autorzy:: Majeed B; Laboratory for Industrial and Applied Mathematics, Department of Mathematics and Statistics, York University, Toronto, ON, Canada.
David JF; Laboratory for Industrial and Applied Mathematics, Department of Mathematics and Statistics, York University, Toronto, ON, Canada.
Bragazzi NL; Laboratory for Industrial and Applied Mathematics, Department of Mathematics and Statistics, York University, Toronto, ON, Canada.
McCarthy Z; Laboratory for Industrial and Applied Mathematics, Department of Mathematics and Statistics, York University, Toronto, ON, Canada.
Grunnill MD; Laboratory for Industrial and Applied Mathematics, Department of Mathematics and Statistics, York University, Toronto, ON, Canada.
Heffernan J; Centre for Disease Modeling, Department of Mathematics and Statistics, York University, Toronto, ON, Canada.; Modelling Infection and Immunity Lab, Department of Mathematics and Statistics, York University, Toronto, ON, Canada.
Wu J; Laboratory for Industrial and Applied Mathematics, Department of Mathematics and Statistics, York University, Toronto, ON, Canada.
Woldegerima WA; Laboratory for Industrial and Applied Mathematics, Department of Mathematics and Statistics, York University, Toronto, ON, Canada.; Pokaż więcej
Źródło:: Frontiers in public health [Front Public Health] 2023 Jan 04; Vol. 10, pp. 1086849. Date of Electronic Publication: 2023 Jan 04 (Print Publication: 2022).
Typ publikacji:: Journal Article
MeSH Terms:: Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza Vaccines*
COVID-19*/epidemiology
COVID-19*/prevention & control
Humans ; Seasons ; Pandemics ; COVID-19 Testing ; SARS-CoV-2 ; Vaccination ; Models, Theoretical
SCR Protocol:: COVID-19 vaccine booster shot

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 20.

Tytuł:: Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021-2022 I-MOVE primary care multicentre study.
Autorzy:: Kissling E; Epiconcept, Paris, France.
Pozo F; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Martínez-Baz I; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.
Buda S; Robert Koch Institut, Berlin, Germany.
Vilcu AM; INSERM, Sorbonne Université, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France.
Domegan L; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
Mazagatos C; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.
Dijkstra F; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Latorre-Margalef N; The Public Health Agency of Sweden, Stockholm, Sweden.
Kurečić Filipović S; Croatian Institute of Public Health, Zagreb, Croatia.
Machado A; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal.
Lazar M; 'Cantacuzino' National Military Medical Institute for Research and Development, Bucharest, Romania.
Casado I; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.
Dürrwald R; Robert Koch Institut, Berlin, Germany.
van der Werf S; Unité de Génétique Moléculaire des Virus à ARN, Institut Pasteur, Université Paris Cité, UMR 3569 CNRS, Paris, France.; CNR virus des infections respiratoires, Institut Pasteur, Paris, France.
O'Donnell J; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
Linares Dopido JA; Subdirección de Epidemiología, Dirección General de Salud Pública, Servicio Extremeño de Salud, Extremadura, Spain.
Meijer A; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Riess M; The Public Health Agency of Sweden, Stockholm, Sweden.
Višekruna Vučina V; Croatian Institute of Public Health, Zagreb, Croatia.
Rodrigues AP; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal.
Mihai ME; 'Cantacuzino' National Military Medical Institute for Research and Development, Bucharest, Romania.
Castilla J; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.
Goerlitz L; Robert Koch Institut, Berlin, Germany.
Falchi A; Laboratoire de Virologie, Université de Corse-Inserm, Corte, France.
Connell J; National Virus Reference Laboratory, University College Dublin, Dublin, Ireland.
Castrillejo D; Servicio de Epidemiología, DGSP, Consejería de Políticas Sociales, Salud Pública y Bienestar Animal, Ciudad Autónoma de Melilla, Melilla, Spain.
Hooiveld M; Nivel, Utrecht, The Netherlands.
Carnahan A; The Public Health Agency of Sweden, Stockholm, Sweden.
Ilić M; Croatian Institute of Public Health, Zagreb, Croatia.
Guiomar R; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal.
Ivanciuc A; 'Cantacuzino' National Military Medical Institute for Research and Development, Bucharest, Romania.
Maurel M; Epiconcept, Paris, France.
Omokanye A; European Centre for Disease Prevention and Control, Stockholm, Sweden.
Valenciano M; Epiconcept, Paris, France.; Pokaż więcej
Corporate Authors:: I-MOVE study team
Źródło:: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2023 Jan; Vol. 17 (1), pp. e13069. Date of Electronic Publication: 2022 Nov 21.
Typ publikacji:: Multicenter Study; Journal Article
MeSH Terms:: Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Humans ; Case-Control Studies ; Europe/epidemiology ; Influenza A Virus, H3N2 Subtype/genetics ; Primary Health Care ; Vaccination ; Vaccine Efficacy ; Male ; Female ; Infant, Newborn ; Infant ; Child, Preschool ; Child ; Adolescent ; Young Adult ; Adult ; Middle Aged ; Aged

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Influenza, Human"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język